Launched in Spain and Colombia in 2020, myBIOME is an innovative gut microbiome examination based on technology developed by Microba’s leading researchers in the field of microbiome analysis. The ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for ...

International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic ...

German laboratory services group Synlab said on Wednesday it planned to float on the stock market, offering investors exposure to a coronavirus testing boom and the consolidation of Europe's ...

The issuer is solely responsible for the content of this announcement. New SYNLAB Manifattura Firenze Medical Centre marks a milestone in the Group's international growth strategy, strengthening local ...

SYNLAB reports a strong start to the fiscal year 2022 12.05.2022 / 07:00 The issuer is solely responsible for the content of this announcement. SYNLAB, the leader in medical diagnostic services and ...

(Reuters) – Buyout group BC Partners has put German laboratory operator Synlab up for sale in a potential deal worth more than 1.5 billion euros ($1.6 billion), three people familiar with the matter ...

SYNLAB Nigeria, a leading provider of medical diagnostic services, has opened an ultra-modern laboratory in Lagos Island, thus giving a boost to genetic testing and preventive healthcare in the ...

SYNLAB, formerly Pathcare Laboratories, has announced the relocation of its Victoria Island branch to 64 Adetokunbo Ademola Street, Victoria Island, Lagos. The company, renowned for high-quality ...